Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
Universidad de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Navarra (13)
2023
-
Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease
European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871
2022
-
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response
Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2018
-
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Biochemical Pharmacology, Vol. 157, pp. 67-84
2016
-
Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis
Stroke, Vol. 47, Núm. 5, pp. 1312-1318
2014
-
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
Human Molecular Genetics, Vol. 23, Núm. 3, pp. 749-754
2013
-
Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 6, pp. 705-717
-
Nrf2 participates in depressive disorders through an anti-inflammatory mechanism
Psychoneuroendocrinology, Vol. 38, Núm. 10, pp. 2010-2022
2012
2010
-
Delayed pre-conditioning by 3-nitropropionic acid prevents 3,4-methylenedioxymetamphetamine-induced 5-HT deficits
Journal of Neurochemistry, Vol. 114, Núm. 3, pp. 843-852
2004
-
Benzimidazole derivatives. Part 5: Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT 1A/5-HT 3 ligands
Bioorganic and Medicinal Chemistry, Vol. 12, Núm. 19, pp. 5181-5191
2003
-
Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands
Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 19, pp. 3177-3180